Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (4815)	7/12/1998 1:23:00 PM
From: Brander	Read Replies (1) \| Respond to of 7041

Linda, in response to: "I think most intelligent people can learn how to evaluate scientific studies, if they have data from the studies." To properly evaluate basic biomedical research papers, someone would need a background in biomedical science, statistics, and research methodology. One does not need an MD or PhD to obtain these skills, but would probably need some formal education in these areas. In response to: "Several MDs have posted here who have drawn negative conclusions about ZONA's studies, and you've apparently drawn positive conclusions." I believe that several MDs have also posted positive remarks about ZONA and Vasomax on this thread. Concerning the studies, my only assertion is that the results suggest statistically that Vasomax works better than placebo in the patient group studied. I am open to be shown otherwise. Brad